Interested parties should wait until July 26 to send contributions.
As of today (07/07), the National Technology Incorporation Commission at SUS – CONITEC makes available immediately the proposal for the elaboration of Clinical Protocols and Therapeutic Directives (PCDT). This time, the topics are: visceral leishmaniasis and tegumentar leishmaniasis.
Visceral leishmaniasis is caused by protozoans of the genus Leishmania It manifests itself as a chronic, systemic disease, characterized by irregular and long-lasting fever, hepatosplenomegaly, lymphadenopathy, emaciation, edema and a state of weakness, associated with laboratory alterations, such as cytopenias, hypergammaglobulinemia and hypoalbuminemia.
The tegumentary leishmaniasis is an infectious disease, with low lethality, not contagious, caused by protozoa of the genus Leishmania, I tend as main species in Brazil to Leishmania (Leishmania) amazonensis, L. (Viannia) guyanensisand L. (V.) braziliensis.
In both cases, with vetorial transmission, chopped peels of insects called phlebotomines, belonging to the genusLutzomyia, popularly known, depending on the geographical location, such as palha mosquito, tatuquira, birigui, among others.
Enquete
The purpose of this is to enable the participation of the society from the first stage (definition of the scope) of the elaboration of the PCDT, allowing the identification of two aspects most relevant to the care. The PCDT are documents that aim to guarantee the best health care in your health, including recommendations of behaviors, medications or products for the different evolutionary phases of a serious health problem or a certain condition.
It will soon be available on July 26. To participate, all you have to do is access the site CONITEC(http://conitec.gov.br/enquetes). Your contribution is extremely important in this entire process!